Britain's regulator has approved Novo Nordisk's weight-loss pill, marking the UK's entry as the first European market for this oral obesity treatment.

The Wegovy semaglutide tablet is taken daily and those with a BMI of 30 or above are eligible

As exclusively revealed by the Daily Mail last week, the Wegovy Pill - the tablet form of the once-weekly Wegovy injection - has been greenlit by health officials.